Sumalpong, Melinda E.
HRN: 14-11-05 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/03/2024
CEFUROXIME 750MG (VIAL)
08/03/2024
08/09/2024
IV
750mg
Q8H
UTI
Rejected
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Non-compliant To Guidelines